Work

Advancing the promises of precision medicine for patients with gastrointestinal stromal tumor

Year: 2019

Type: article

Abstract: Gastrointestinal stromal tumor (GIST) treatment is one of the best examples of how precision medicine can impact outcomes in patients with cancer. In 1998, Hirota and colleagues reported that GISTs carried gain-of-function mutations in the proto-oncogene, c-KIT (1). Although considered a rare malignancy, GIST is the most common mesenchymal neoplasm of the gastrointestinal tract (2-4).

Source: Gastrointestinal Stromal Tumor

DOI: 10.21037/gist.2019.10.01

Authors: Joaquina C. Baranda, Andrew K. Godwin

Institutions: University of Kansas, The University of Kansas Cancer Center, University of Kansas Medical Center

Language: English

Topic: Gastrointestinal Tumor Research and Treatment

Subfield: Gastroenterology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: diamond

OpenAlex ID: W2993633535

FWCI:

Cites:

Cited by: 1

Related to: 10